Publication Cover
Global Public Health
An International Journal for Research, Policy and Practice
Volume 10, 2015 - Issue 8
309
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Legal and policy foundations for global generic competition: Promoting affordable drug pricing in developing societies

Pages 901-916 | Received 10 Apr 2014, Accepted 21 Jan 2015, Published online: 04 Mar 2015

References

  • Abbott, F. (2005). The WTO medicines decision: World pharmaceutical trade and the protection of public health. American Journal of International Law, 99, 317–358. Retrieved from http://www.who.int/intellectualproperty/submissions/Abbott%20proofs.pdf
  • Abbott, F., & Reichman, J. (2007). The Doha Round's public health legacy: Strategies for the production and diffusion of patented medicines under the amended TRIPs provisions. Journal of International Economic Law, 10, 921–987. doi:10.1093/jiel/jgm040
  • Avafia, T., Berger, J., & Hartzenberg, T. (2006). The ability of select sub-Saharan African countries to utilize TRIPS flexibilities and competition law to ensure a sustainable supply of essential medicines: A study of producing and importing countries (Working Paper No. 12). Retrieved from http://www.eldis.org/go/home&id=23768&type=Document#.VMtwdXvQrPI
  • Berger, J. (2004, October). Advancing public health by other means: Using competition policy to increase access to essential medicines. Paper presented at the Bellagio Series on Development and Intellectual Property Policy: Policy Options for Assuring Affordable Access to Essential Medicines, Geneva.
  • Bermudez, J., & ‘t Hohen, E. (2010). The UNITAID patent pool initiative: Bringing patents together for the common good. Open AIDS Journal, 4, 37–40. doi:10.2174/1874613601004020037
  • Bradford, V., & Lee, K. (2007). TRIPS, the Doha declaration and paragraph 6 decision: What are the remaining steps for protecting access to medicines? Globalization and Health, 3, 3. doi:10.1186/1744-8603-3-3
  • O’Connor, J. F. (1991). Good faith in international law. Aldershot: Dartmouth.
  • Correa, C. (2004). Implementation of the WTO General Council Decision on paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Health Economics and Drugs Series No. 106). Geneva: World Health Organization.
  • Correa, C. (2010). Intellectual property rights and public health: The general context and main TRIPS compliant flexibilities. In The World Health Organization (Ed.), Intellectual property and access to medicines: Papers and perspectives (pp. 1–10). Geneva: World Health Organization.
  • Drahos, P. (2001). BITs and BIPs: Bilateralism in intellectual property. The Journal of World Intellectual Property, 4, 791–808. doi:10.1111/j.1747-1796.2001.tb00138.x
  • Drahos, P., & Braithwaite, J. (2002). Information feudalism: Who owns the knowledge economy? London: Earthscan.
  • Drexl, J. (2005). The critical role of competition law in preserving public goods in conflict with intellectual property rights. In K. E. Maskus & J. H. Reichman (Eds.), International public goods and transfer of technology under a globalized intellectual property regime (pp. 709–725). London: Cambridge University Press.
  • European Commission. (2010). DG Competition: 1st report on the monitoring of patent settlements. Retrieved from http://ec.europa.eu/competition/sectors/pharmaceuticals/inquiry/patent_settlements_report1.pdf
  • European Commission. (2011). DG competition: 2nd report on the monitoring of patent settlements. Retrieved from http://ec.europa.eu/competition/sectors/pharmaceuticals/inquiry/patent_settlements_report2.pdf
  • Fink, C. (2003). Implementing the Doha mandate on TRIPS and public health (World Bank Trade Note 5). Retrieved from http://documents.worldbank.org/curated/en/2003/05/2543538/implementing-doha-mandate-trips-public-health
  • Fox, E. (2005). Can antitrust policy protect the global commons from the excesses of IPRs? In K. E. Maskus & J. H. Reichman (Eds.), International public goods and transfer of technology under a globalized intellectual property regime (pp. 758–769). London: Cambridge University Press.
  • Gallini, N., & Trebilcock, M. (1998). Competition policy and intellectual property rights. In R. D. Anderson & N. T. Gallini (Eds.), Competition policy and intellectual property rights in the knowledge-based economy (pp. 17–61). Calgary: University of Calgary Press.
  • Ghidini, G. (2006). Intellectual property and competition law: The innovation nexus. Cheltenham: Edward Elgar.
  • ‘t Hoen, E. (2009). The global politics of pharmaceutical monopoly power: Drug patents, access, innovation and the application of the WTO Doha Declaration on TRIPS and Public Health. Ramsey, MN: AMB.
  • Kur, A., & Ruse-Khan, H. (2008). Enough is enoughThe notion of binding ceilings in international intellectual property protection (Max Planck Institute for Intellectual Property, Competition & Tax Law Research Paper Series No. 09-01). Retrieved from http://hdl.handle.net/11858/00-001M-0000-0011-424D-2
  • Lamy, P. (2012, February). Strong competition policies key to a dynamic and healthy market economy. Speech presented at the OECD Global Forum on Competition, Paris.
  • Love, J. (2011). The core valve compulsory license on patent to treat aortic stenosis. Washington, DC: Knowledge Ecology International.
  • Matthews, D. (2004). WTO Decision on implementation of paragraph 6 of the Doha Declaration on TRIPS agreement and public health: A solution to the access to essential medicines problem? Journal of International Economic Law, 7, 73–107. doi:10.1093/jiel/7.1.73
  • Picciotto, S. (2002). Defending the public interest in TRIPS and the WTO. In P. Drahos & R. Mayne (Eds.), Global intellectual property rights: Knowledge, access and development (pp. 224–243). London: Palgrave-Oxfam.
  • Picciotto, S., & Campbell, D. (2003). Whose molecule is it anyway? Private and social perspectives on intellectual property. In A. Husdon (Ed.), New perspectives on property law, obligations and restitution (pp. 279–303). London: Cavendish.
  • Pugatch, M. (2005). The international regulation of IPRs in a TRIPS and TRIPS plus world. Journal of World Investment and Trade, 6, 430–465.
  • Reichman, J. (1996). From free riders to fair followers: Global competition under the TRIPS agreement. New York University Journal of International Law and Politics, 29, 12–93. Retrieved from http://scholarship.law.duke.edu/faculty_scholarship/95/
  • Reichman, J. (2001). Of green tulips and legal kudzu: Repackaging rights in subpatentable innovation. In R. C. Dreyfuss (Ed.), Expanding the boundaries of intellectual property: Innovation policy for the information society (pp. 23–53). Oxford: Oxford University Press.
  • Reichman, J. (2009). Compulsory licensing of patented pharmaceutical inventions: Evaluating the options. Journal of Law Medicine, 37, 247–263. doi:10.1111/j.1748-720X.2009.00369.x
  • Scherer, F. M. (2000). Competition policy, domestic and international. Cheltenham: E. Elgar.
  • Scherer, F. (2004). A note on global welfare in pharmaceutical patenting. World Economy, 27, 1127–1142. doi:10.2139/ssrn.570565
  • Sell, S. (2007). TRIPS-Plus free trade agreements and access to medicines. Liverpool Law Review, 28, 41–72. doi:10.1007/s10991-007-9011-8
  • Serafino, D. (2007). Survey of patent pools demonstrates variety of purposes and management structures (KEI Research Note 2007:6). Washington, DC: Knowledge Ecology International.
  • Thailand Ministry of Public Health and National Health Security Office. (2007). Facts and evidence on the 10 burning issues related to the government use of patents on three patented essential drugs in Thailand. Retrieved from http://apps.who.int/medicinedocs/documents/s18718en/s18718en.pdf
  • United Nations Development Program (UNDP). (1999). UNDP human development report 1999. New York, NY: Oxford University Press.
  • Waning, B., Kyle, M., Diedrichsen, E., Soucy, L., Hochstadt, J., Bärnighausen, T., & Moon, S. (2010). Intervening in global markets to improve access to HIV/AIDS treatment: An analysis of international policies and the dynamics of global antiretroviral medicines markets. Globalization and Health, 6, 9. doi:10.1186/1744-8603-6-9
  • World Health Organization – Commission on Intellectual Property Rights, Innovation and Public Health (WHO). (2006). Public health, innovation and intellectual property rights. Geneva: Author.
  • World Health Organization (WHO). (2008). Global strategy and plan of action on public health, innovation and intellectual property. Retrieved from http://www.who.int/phi/implementation/phi_globstat_action/en/
  • World Intellectual Property Organization (WIPO). (2007). WIPO development agenda [press release]. Retrieved from http://www.wipo.int/pressroom/en/articles/2007/article_0071.html
  • World Intellectual Property Organization (WIPO). (2010). Exceptions and limitations to patents rights, Brazil proposal. Retrieved from www.wipo.int/edocs/mdocs/patent_policy/en/scp_14/scp_14_7.pdf
  • World Intellectual Property Organization (WIPO). (2011). Proposal submitted by the Delegation of South Africa on behalf of the African Group and the Development Agenda Group. Retrieved from http://www.wipo.int/meetings/en/doc_details.jsp?doc_id=287111
  • World Trade Organization (WTO). (1997). India-patent protection for pharmaceutical and agricultural chemical products. Retrieved from http://www.wto.org/english/tratop_e/dispu_e/cases_e/ds50_e.htm
  • World Trade Organization (WTO). (1998). India-patent protection for pharmaceutical and agricultural chemical products. Retrieved from http://www.wto.org/english/tratop_e/dispu_e/79r.pdf
  • World Trade Organization (WTO). (2001). Doha declaration on the TRIPs agreements and public health. Retrieved from http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm
  • World Trade Organization (WTO). (2003a). Council for trade-related aspects of intellectual property rights - Implementation of Article 66.2 of the TRIPS agreement - decision of the council for TRIPS. Retrieved from https://www.wto.org/english/tratop_e/trips_e/ta_docs_e/ipc28_e.pdf
  • World Trade Organization (WTO). (2003b). Implementation of paragraph 6 of the Doha declaration on the TRIPS agreement and public health: Decision of the general council of 30 August 2003. Retrieved from www.wto.org/english/tratop_e/trips_e/ta_docs_e/3_wtl540_e.pdf
  • World Trade Organization (WTO). (2007a). Council for trade-related aspects of intellectual property rightsNotification under paragraph 2(a) of the Decision of 30 August 2003Rwanda. Retrieved from www.wto.org/english/tratop_e/trips_e/ta_docs_e/3_ipn9rwa1_e.pdf
  • World Trade Organization (WTO). (2007b). Council for trade-related aspects of intellectual property rights - Notification under paragraph 2(c) of the Decision of 30 August 2003Canada. Retrieved from www.wto.org/english/tratop_e/trips_e/ta_docs_e/3_ipn10can1_e.pdf
  • World Trade Organization (WTO). (2011). Annual review of the decision on the implementation of paragraph 6 of the Doha Declaration on the TRIPs agreement and public health (Report to the General Council). Retrieved from http://www.wto.org/english/tratop_e/trips_e/ta_docs_e/3_ipc61_e.pdf
  • World Trade Organization (WTO). (2012). Council for trade-related aspects of intellectual property rights: Minutes of meeting. Retrieved from https://docs.wto.org/dol2fe/Pages/FE_Search/FE_S_S009-DP.aspx?language=E&CatalogueIdList=42186,38092,99228,99226,99746,108518,103728,96161,98545,96162&CurrentCatalogueIdIndex=0&FullTextSearch=
  • Zapatero Miguel, P. (2014).Trade in generics vs. world-scale market segmentation: Market-driven solutions to the ‘paragraph 6’ issue. Journal of World Trade, 48, 81–110. Retrieved from https://www.kluwerlawonline.com/abstract.php?area=Journals&id=TRAD2014004

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.